Tobramycin-responsive Fusarium oxysporum keratitis.
Chodosh
J
J
Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, Fla., USA.
Miller
D
D
Tu
E Y
EY
Culbertson
W W
WW
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003315:Cornea / Q000382:microbiology* / Q000473:pathology; D003320:Corneal Ulcer / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D015821:Eye Infections, Fungal / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D005670:Fusarium / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D009883:Ophthalmic Solutions; D014031:Tobramycin / Q000008:administration & dosage / Q000627:therapeutic use*; D014640:Vancomycin / Q000008:administration & dosage / Q000627:therapeutic use; D014792:Visual Acuity
D000900:Anti-Bacterial Agents; D009883:Ophthalmic Solutions; D014640:Vancomycin; D014031:Tobramycin